Daiqin Chen Selected Research

fullerene C70

8/2020	Fullerene nanoparticles: a promising candidate for the alleviation of silicosis-associated pulmonary inflammation.
10/2016	Fullerene/photosensitizer nanovesicles as highly efficient and clearable phototheranostics with enhanced tumor accumulation for cancer therapy.
2/2015	Amphiphilic trismethylpyridylporphyrin-fullerene (C70) dyad: an efficient photosensitizer under hypoxia conditions.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Daiqin Chen Research Topics

Disease

13	Neoplasms (Cancer) 01/2021 - 02/2013
3	Neoplasm Metastasis (Metastasis) 01/2021 - 10/2016
2	Breast Neoplasms (Breast Cancer) 01/2017 - 10/2016
1	Triple Negative Breast Neoplasms 01/2021
1	Silicosis 08/2020
1	Pneumonia (Pneumonitis) 08/2020
1	Lung Injury 08/2020
1	Inflammation (Inflammations) 08/2020
1	Occupational Diseases (Occupational Disease) 08/2020
1	Glioblastoma (Glioblastoma Multiforme) 06/2019
1	Hypoxia (Hypoxemia) 02/2015
1	Pathologic Processes 04/2014

Drug/Important Bio-Agent (IBA)

3	fullerene C70IBA 08/2020 - 02/2015
3	FullerenesIBA 08/2020 - 10/2016
3	CarbonIBA 01/2019 - 07/2015
2	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 01/2021 - 11/2016
2	Monoclonal AntibodiesIBA 01/2021 - 10/2016
2	Plasminogen Activators (Plasminogen Activator)IBA 01/2021 - 11/2016
2	Alanine (L-Alanine)FDA Link 08/2020 - 06/2019
2	Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric 06/2019 - 01/2017
2	LigandsIBA 06/2019 - 01/2017
2	gadofullereneIBA 06/2019 - 01/2019
2	Oxygen (Dioxygen)IBA 01/2019 - 02/2015
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2019 - 01/2018
2	Photosensitizing Agents (Photosensitizers)IBA 10/2016 - 02/2015
1	Immunoglobulin FragmentsIBA 01/2021
1	Silicon Dioxide (Silica)FDA LinkGeneric 08/2020
1	Hydroxyl RadicalIBA 08/2020
1	1,4,7- triazacyclononane- N,N',N''- triacetic acid (NOTA)IBA 06/2019
1	triazacyclononaneIBA 06/2019
1	AcidsIBA 06/2019
1	AminesIBA 06/2019
1	IsotopesIBA 06/2019
1	MetalloproteinsIBA 01/2019
1	Glutathione (Reduced Glutathione)IBA 01/2018
1	Nanoparticle Drug Delivery SystemIBA 01/2018
1	Metal-Organic FrameworksIBA 01/2017
1	Prostaglandins AIBA 01/2017
1	NucleolinIBA 01/2017
1	Peptides (Polypeptides)IBA 01/2017
1	pyreneIBA 01/2017
1	Urokinase Plasminogen Activator ReceptorsIBA 11/2016
1	SolutionsIBA 11/2016
1	gadoteridol (Prohance)FDA Link 11/2016
1	Human Serum Albumin FDA LinkGeneric 11/2016
1	LuciferasesIBA 10/2016
1	graphene oxideIBA 10/2016
1	FSH Receptors (FSH Receptor)IBA 10/2016
1	phytochlorinIBA 10/2016
1	malonic acid (malonate)IBA 10/2016
1	GraphiteIBA 01/2016
1	GadoliniumIBA 01/2016
1	Carbon Nanotubes (Carbon Nanotube)IBA 01/2016
1	Pharmaceutical PreparationsIBA 07/2015
1	1-phenyl-3,3-dimethyltriazene (PDT)IBA 02/2015
1	Singlet OxygenIBA 02/2015
1	PorphyrinsIBA 02/2015
1	Heme (Haem)IBA 04/2014
1	MicellesIBA 02/2013

Therapy/Procedure

6	Therapeutics 01/2019 - 02/2013
4	Precision Medicine 01/2017 - 07/2015
3	Photochemotherapy (Photodynamic Therapy) 10/2016 - 02/2015
1	Intravenous Injections 10/2016
1	Drug Therapy (Chemotherapy) 08/2014
1	Lasers (Laser) 02/2013